111 related articles for article (PubMed ID: 10688218)
21. DNA typing for Helicobacter pylori isolates from eradication-failed patients: comparison of the isolates before and after therapy.
Nada T; Ando T; Nobata K; Tsuzuki T; Minami M; Ina K; Iinuma Y; Ichiyama S; Ohta M; El-Omar E; Kusugami K; Goto H
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():39-47. PubMed ID: 15298604
[TBL] [Abstract][Full Text] [Related]
22. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.
Hong SS; Jung HY; Choi KD; Song HJ; Lee GH; Oh TH; Jo JY; Kim KJ; Byeon JS; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI
Helicobacter; 2006 Dec; 11(6):569-73. PubMed ID: 17083379
[TBL] [Abstract][Full Text] [Related]
23. The results of Helicobacter pylori eradication on repeated bleeding in patients with stomach ulcer.
Horvat D; Vcev A; Soldo I; Timarac J; Dmitrović B; Misević T; Ivezić Z; Kraljik N
Coll Antropol; 2005 Jun; 29(1):139-42. PubMed ID: 16117312
[TBL] [Abstract][Full Text] [Related]
24. Childhood Helicobacter pylori infection, clinical presentations, endoscopic, histologic features and results of treatment.
Vithayasai N
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S600-4. PubMed ID: 14700155
[TBL] [Abstract][Full Text] [Related]
25. [Regression of primary low-grade gastric mucosa-associated lymphoma by eradication of Helicobacter pylori infection: case report].
Sciumè C; Geraci G; Pisello F; Li Volsi F; Facella T; Modica G
Ann Ital Chir; 2004; 75(1):63-8; discussion 69. PubMed ID: 15283390
[TBL] [Abstract][Full Text] [Related]
26. [The association between Helicobacter pylori and gastric neoplasia. Epidemiologic evidence].
Guarner J; Mohar A
Rev Gastroenterol Mex; 2000; 65(4 Suppl 2):20-4. PubMed ID: 11464618
[TBL] [Abstract][Full Text] [Related]
27. Influence of Helicobacter pylori eradication therapy on the occurrence of gastrointestinal events in patients treated with conventional nonsteroidal antiinflammatory drugs combined with omeprazole.
Bannwarth B; Dorval E; Caekaert A; Barthelemy P
J Rheumatol; 2002 Sep; 29(9):1975-80. PubMed ID: 12233895
[TBL] [Abstract][Full Text] [Related]
28. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
[TBL] [Abstract][Full Text] [Related]
29. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
Nagahara A; Miwa H; Kawabe M; Kurosawa A; Asaoka D; Hojo M; Iijima K; Terai T; Ohkusa T; Miyazaki A; Sato N
J Gastroenterol; 2004 Nov; 39(11):1051-5. PubMed ID: 15580397
[TBL] [Abstract][Full Text] [Related]
30. Duration of the metronidazole-containing regimen for eradication of Helicobacter pylori infection in northern Japan.
Fukuda S; Shimoyama T; Tanaka M; Nakasato F; Fukushi M; Munakata A
Jpn J Infect Dis; 2006 Dec; 59(6):367-9. PubMed ID: 17186954
[TBL] [Abstract][Full Text] [Related]
31. Design and planned analyses of an ongoing randomized trial assessing the preventive effect of Helicobacter pylori eradication on occurrence of new gastric carcinomas after endoscopic resection.
Kikuchi S; Kato M; Katsuyama T; Tominaga S; Asaka M
Helicobacter; 2006 Jun; 11(3):147-51. PubMed ID: 16684261
[TBL] [Abstract][Full Text] [Related]
32. [The efficacy of the Helicobacter pylori eradication in people of an advanced age].
Kopański Z; Piekoszewski W; Schlegel-Zawadzka M; Witkowska B; Tabak J; Puto T; Trebacz P; Szuszko R
Przegl Lek; 2002; 59(4-5):262-4. PubMed ID: 12183983
[TBL] [Abstract][Full Text] [Related]
33. Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage--a long-term randomized, controlled study.
Lai KC; Hui WM; Wong WM; Wong BC; Hu WH; Ching CK; Lam SK
Am J Gastroenterol; 2000 Sep; 95(9):2225-32. PubMed ID: 11007222
[TBL] [Abstract][Full Text] [Related]
34. A randomized trial of triple therapy for pediatric Helicobacter pylori infection and risk factors for treatment failure in a population with a high prevalence of infection.
Gessner BD; Bruce MG; Parkinson AJ; Gold BD; Muth PT; Dunaway E; Baggett HC
Clin Infect Dis; 2005 Nov; 41(9):1261-8. PubMed ID: 16206100
[TBL] [Abstract][Full Text] [Related]
35. Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
Wong WM; Gu Q; Chu KM; Yee YK; Fung FM; Tong TS; Chan AO; Lai KC; Chan CK; Wong BC
Aliment Pharmacol Ther; 2006 Feb; 23(3):421-7. PubMed ID: 16423001
[TBL] [Abstract][Full Text] [Related]
36. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
[TBL] [Abstract][Full Text] [Related]
37. [What is currently the Helicobacter pylori eradication therapy of choice? Triple therapy (PPI, amoxicillin and clarithromycin) or sequential therapy (PPI and amoxicillin for 5 days followed by PPI, clarithromycin and metronidazole for a further 5 days)?].
Sánchez-Delgado J
Gastroenterol Hepatol; 2009 Jan; 32(1):68-9. PubMed ID: 19174106
[No Abstract] [Full Text] [Related]
38. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
[TBL] [Abstract][Full Text] [Related]
39. Effects of Helicobacter pylori eradication among adults with intellectual disability.
Wallace RA; Schluter PJ; Webb PM
J Intellect Disabil Res; 2004 Oct; 48(Pt 7):646-54. PubMed ID: 15357684
[TBL] [Abstract][Full Text] [Related]
40. Details of hyperplastic polyps of the stomach shrinking after anti-Helicobacter pylori therapy.
Nakajima A; Matsuhashi N; Yazaki Y; Oka T; Sugano K
J Gastroenterol; 2000; 35(5):372-5. PubMed ID: 10832673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
